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Type 1 cannabinoid receptor (CB1) is the principal mediator of retrograde 
endocannabinoid signaling in the brain. In this study, we addressed the topographic 
distribution and amino acid neurotransmitter phenotype of endocannabinoid-sensitive 
hypothalamic neurons in mice. The in situ hybridization detection of CB1 mRNA 
revealed high levels of expression in the medial septum (MS) and the diagonal band 
of Broca (DBB), moderate levels in the preoptic area and the hypothalamic 
lateroanterior (LA), paraventricular (Pa), ventromedial (VMH), lateral mammillary 
(LM) and ventral premammillary (PMV) nuclei, and low levels in many other 
hypothalamic regions including the suprachiasmatic (SCh) and arcuate (Arc) nuclei. 
This regional distribution pattern was compared to location of GABAergic and 
glutamatergic cell groups, as identified by the expression of glutamic acid 
decarboxylase 65 (GAD65) and type 2 vesicular glutamate transporter (VGLUT2) 
mRNAs, respectively. The MS, DBB and preoptic area showed overlaps between 
GABAergic and CB1-expressing neurons, whereas hypothalamic sites with moderate 
CB1 signals, including the LA, Pa, VMH, LM and PMV, were dominated by 
glutamatergic neurons. Low CB1 mRNA levels were also present in other 
glutamatergic and GABAergic regions. Dual-label in situ hybridization experiments 
confirmed the cellular co-expression of CB1 with both glutamatergic and GABAergic 
markers. In this report we provide a detailed anatomical map of hypothalamic 
glutamatergic and GABAergic systems whose neurotransmitter release is controlled 
by retrograde endocannabinoid signaling from hypothalamic and extrahypothalamic 
target neurons. This neuroanatomical information contributes to the understanding of 





Endocannabinoids modulate brain neurotransmission primarily via acting on type 1 
cannabinoid receptor (CB1) localized on presynaptic axon terminals (Pagotto et al., 
2006; Piomelli, 2003). Activation of CB1 by endogenous lipid ligands including 
anandamide (Devane et al., 1992) and 2-arachidonoyl-glycerol (2-AG) (Mechoulam 
et al., 1995) decreases the synaptic release of GABA (Hoffman and Lupica, 2000), 
glutamate (Gerdeman and Lovinger, 2001; Huang et al., 2001), acetylcholine 
(Degroot et al., 2006), noradrenaline (Vizi et al., 2001) and possibly, other 
neurotransmitters. CB1 is one of the most abundant G-protein-coupled receptors 
which is distributed widely in the rodent brain (Bellocchio et al., 2010; Herkenham et 
al., 1990; Katona et al., 2001; Katona et al., 1999; Marsicano and Lutz, 1999; 
Matsuda et al., 1993; McDonald and Mascagni, 2001; Tsou et al., 1998).  
Endocannabinoids exert profound effects on hypothalamic functions, including 
endocrine hormone secretion, appetite, food intake and energy balance (for a review, 
see: (Pagotto et al., 2006)). Somewhat conflictingly, previous studies only detected a 
low abundance of CB1 immunoreactive axons (Tsou et al., 1998) and a low 
expression level of CB1 mRNA (Cota et al., 2003; Marsicano and Lutz, 1999) in the 
rodent hypothalamus, leaving the central regulatory mechanisms unexplained. A 
more recent immunocytochemical mapping study (Wittmann et al., 2007) from our 
laboratory, which used a newly developed CB1 antiserum (Fukudome et al., 2004), 
revealed an unexpectedly dense CB1-immunoreactive fiber network in the mouse 
hypothalamus. The CB1-immunoreactive terminals established symmetric as well as 
asymmetric synapses, indicating that retrograde endocannabinoid signaling in the 
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hypothalamus can influence inhibitory and excitatory synaptic transmission, 
respectively. The lack of previous immunocytochemical proof for this surprisingly 
dense CB1 immunoreactive input to hypothalamic neurons and the previous evidence 
that CB1 can be synthesized at highly variable levels in distinct classes of neurons 
elsewhere in the brain (Katona et al., 2006), suggest that the detection sensitivity is 
critical to successfully visualize moderate or low levels of CB1. This is apparently a 
problem when in situ hybridization is used to visualize CB1 expression. Neurons of 
the rodent hypothalamus only seem to contain low levels of CB1 mRNA, observed 
primarily in non-GABAergic cells of the ventromedial and anterior hypothalamic 
nuclei (Marsicano and Lutz, 1999) and in specific subsets of peptidergic neurons in 
the paraventricular nucleus (Cota et al., 2003).  
While partial information already exists about the topography and phenotype of 
hypothalamic CB1 expressing neurons (Bellocchio et al., 2010; Cota et al., 2003; 
Marsicano and Lutz, 1999; Matsuda et al., 1993), there is no comprehensive study 
available about the presence, signal level and amino acid neurotransmitter phenotype 
of CB1 mRNA expressing neurons in distinct septal/hypothalamic regions of the 
mouse. In the present study we used an improved radioisotopic in situ hybridization 
technique (Hrabovszky and Petersen, 2002) to establish a detailed map of CB1 
mRNA-expressing neurons. To also identify the amino acid neurotransmitter 
phenotype of these endocannabinoid-sensitive cells, the CB1 expression map was 
compared to the distribution of GABAergic and glutamatergic septal/hypothalamic 
neurons, characterized by the expression of glutamic acid decarboxylase 65 (GAD65) 
and type 2 vesicular glutamate transporter (VGLUT2) mRNAs, respectively. Finally, 
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dual-label in situ hybridization experiments were carried out to confirm the cellular 




Adult male CD1 mice (N=10; 30-35 g BW) derived from a local breeding colony at 
the Medical Gene Technology Unit of the Institute of Experimental Medicine were 
used for the experiments. They were housed under standard environmental conditions 
(lights on between 0600–1800 h, temperature 22±1 C, humidity 6010%, standard 
rodent chow and water ad libitum). All experiments were carried out in accordance 
with the Council Directive of 24 November 1986 of the European Communities 
(86/609/EEC) and were reviewed and approved by the Animal Welfare Committee of 
the Institute of Experimental Medicine (47/003/2005).  
Preparation of the mouse CB1 probe 
To prepare a cRNA hybridization probe to mouse CB1 receptor mRNA, a 1368-bp 
cDNA fragment was amplified with polymerase chain reaction from mouse 
hypothalamic cDNA. The amplicon (corresponding to bases 579-1946 of the mouse 
CB1 mRNA; NM_007726.2) was inserted into plasmid vector using the PGEM T 
cloning kit from Promega (Madison, WI). The plasmid was grown in DH5α cells 
(Invitrogen, Carlsbad, CA, USA), isolated with the QIAfilter Plasmid Maxi kit 
(Qiagen; Valencia, CA, USA), linearized with Sal I and purified with 
phenol/chloroform/isoamyl alcohol (PCI), followed by chloroform/isoamyl alcohol 
(CI) extractions, and then, precipitation with NaCl and ethanol. The linearized 
transcription template was transcribed with T7 RNA polymerase in the presence of 
35S-UTP (NEN Life Science Products, Boston, MA, USA), to yield antisense 
transcripts (Hrabovszky et al., 2004). To generate a sense control for specificity 
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testing, the insert was cleaved at an internal ApaI site and a 1 Kb sense transcript was 
transcribed using the SP6 promoter site.  
Preparation of the mouse GAD65 and VGLUT2 probes 
Templates to generate probes to the GABAergic and glutamatergic marker 
enzymes, GAD65 and VGLUT2, respectively, were prepared with the PGEM T 
cloning kit, as described above for the CB1 cDNA. The inserts corresponded to bases 
166-994 of mGAD65 (NM_008078) and bases 1762-2390 of mVGLUT2 
(NM_080853) mRNAs. Probes for single-labeling experiments were transcribed in 
the presence of 35S-UTP. 
Single-label in situ hybridization studies  
Tissue preparation  
Five mice were decapitated. The brains were removed and snap-frozen on 
powdered dry ice. Then 12-μm-thick coronal sections were cut from the septal and 
hypothalamic regions of the frozen tissues using a Leica CM 3050 S cryostat (Leica 
Microsystems, Vienna, Austria), thaw-mounted on microscope slides coated with (3-
Aminopropyl) triethoxy-silane (Sigma, St. Louis, MO, USA), and air-dried. The 
sections were then processed for the radioisotopic in situ hybridization detection of 
CB1 mRNA.  
Prehybridization tissue treatments 
Prior to hybridization, the sections were pretreated as described elsewhere 
(Hrabovszky et al., 2004). Briefly, they were fixed in 4% paraformaldehyde for 15 
min, acetylated with 0.25% acetic anhydride in 0.9% NaCl/0.1 M triethanolamine 
(Sigma; pH 8.0) for 10 min, rinsed in standard saline citrate solution (2XSSC; 1X 
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SSC=0.15 M NaCl/0.015 M sodium citrate, pH 7.0) for 2 min, dehydrated in 70, 80, 
95 and 100% ethanol (2 min each), delipidated in chloroform for 5 min, and finally, 
rehydrated partially in 100%, followed by 95% ethanol (2 min each) and air dried.  
Hybridization and posthybridization 
Every tenth hypothalamic section from each of five mice, was hybridized with a 
35S-labeled antisense probe against mouse CB1 mRNA. Further two series consisting 
of immediate neighbors of these sections were hybridized to the antisense VGLUT2 
and the antisense GAD65 probes, respectively, whereas one series was Nissl-stained 
with cresyl violet, to facilitate anatomical analysis. Sections hybridized with sense 
transcripts were processed in parallel, to serve as negative controls. To prevent the 
formation of autoradiographic background in the hybridization experiments, high 
concentrations of dithiothreitol (1000 mM) were added to the hybridization buffer 
(Hrabovszky and Petersen, 2002). To enhance hybridization signal and allow single-
cell detection of low signal levels, high concentrations of radioisotopic probe (80,000 
cpm/μl) and dextran sulfate (20%) were used in the hybridization solution 
(Hrabovszky and Petersen, 2002). Following an overnight hybridization at 52 C, the 
non-specifically bound probe was digested with 20 µg/ml ribonuclease A (Sigma; 
dissolved in 0.5 M NaCl/10 mMTris-HCl/1 mM EDTA; pH 7.8) for 60 min at 37 oC, 
followed by a stringent treatment step to further clear the background (55 C in 0.1X 
SSC solution for 60 min). The slides were dipped into MQ water for 2 sec, rinsed in 
70% ethanol for 5 min and air-dried.  
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Autoradiography 
The slides were exposed to Kodak BioMax MR autoradiography films for 5 days 
and the signal was developed with standard procedures. Then the sections were 
coated with Kodak NTB nuclear track emulsion (Kodak; Rochester, NY; diluted 1:1 
with distilled water) and exposed for 3 weeks. The autoradiographs were visualized 
with Kodak processing chemicals. The sections were lightly counterstained with 
0.05% Toluidine blue (Sigma) to enable the distinction of hypothalamic nuclei, then 
dehydrated with 95%, followed by 100% ethanol (five min each), cleared with xylene 
(2X5 minutes), and coverslipped with DPX mounting medium (Fluka Chemie; Buchs, 
Switzerland). 
Dual-label in situ hybridization studies  
To demonstrate the cellular coexpression of CB1 with GAD65 or CB1 with 
VGLUT2 mRNAs, five mice were deeply anesthetized with a cocktail of ketamine 
(25 mg/kg), xylavet (5 mg/kg) and pipolphen (2.5 mg/kg) in saline and sacrificed by 
transcardiac perfusion with 10 ml 0.1M phosphate buffered saline (PBS) followed by 
40 ml of 4% paraformaldehyde in 0.1M phosphate buffered saline. The brains were 
removed, postfixed for 1 h in the same fixative, infiltrated with 20% sucrose 
overnight and then, snap-frozen on dry-ice. Septal-hypothalamic blocks were 
dissected and 25-µm-thick coronal sections were cut on a freezing microtome (Leica). 
Every fourth section was processed to colocalize CB1 with GAD65 mRNA. A second 
series was processed similarly to study CB1/VGLUT2 coexpression. The floating 
sections were acetylated with 0.25% acetic anhydride in 0.9% NaCl/0.1 M 
triethanolamine-HCl for 10 min, rinsed in 2X SSC for 2 min, treated sequentially 
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with 50%, 70% and 50% acetone (5 min each), rinsed with 2X SSC and transferred 
into hybridization solution containing a cocktail of the radioisotopic CB1 probe 
(80,000cpm/µl) and the digoxigenin-labeled mGAD65 or mVGLUT2 hybridization 
probe (1:50 dilution) in PCR tubes. The hybridization buffer included 1000 mM DTT, 
and unlike for single-labeling, 10%, instead of 20% dextran sulfate. The digoxigenin-
labeled mGAD65 and mVGLUT2 probes were transcribed in vitro in the presence of 
digoxigenin-11-UTP (Roche Diagnostics Co., Indianapolis, IN, USA) as detailed 
previously (Hrabovszky et al., 2004). Following the use of posthybridization 
treatments (see under single-labeling), the floated sections were rinsed briefly with 
100 mM maleate buffer (pH 7.5) and blocked for 30 min against non-specific 
antibody binding with 2% blocking reagent (Roche) in maleate buffer. Then anti-
digoxigenin antibodies conjugated to horseradish peroxidase (anti-digoxigenin-POD; 
Fab fragment; 1:100; Roche) were applied to the sections overnight at 4oC. To 
visualize the enzyme reaction, the sections were first rinsed in TBS (0.1 M Tris-HCl 
with 0.9% NaCl; pH 7.8), then incubated for 30 min with biotinylated tyramide 
working solution (TSA kit; NEN Life Science Products, Boston, MA) according to 
the manufacturer’s instructions (NEN). Following biotin tyramide deposition and 
brief rinses in TBS, the sections were transferred into the ABC-alkaline phosphatase 
(AP) reagent (Vector, Burlingame, CA; 1:1000) for 1 h. The enzyme reaction was 
visualized with the 5-bromo-4-chloro-3-indolyl-phosphate/4-nitro blue tetrazolium 
(BCIP/NBT) chromogen system according to the manufacturer’s instructions 
(Roche). The development of purple color reaction was monitored at intervals and 
stopped after 120 minutes. The sections were mounted on gelatin-coated microscope 
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slides and dipped sequentially twice into 1% Parlodion (Mallinckrodt; St. Louis, MO, 
USA) in amyl acetate. This step can efficiently prevent positive chemography (high 
autoradiographic background) associated with the use of the BCIP/NBT chromogen 
in dual-label in situ hybridization experiments (Hrabovszky et al., 2006; Hrabovszky 
et al., 2004; Hrabovszky et al., 1995). Then, the autoradiographic signal was detected 
with Kodak NTB emulsion in the same way as in single-labeling experiments. 
Microscopic analysis 
 
Dark-field images of emulsion autoradiographs from single-labeling experiments 
were scanned with an AxioCam MRc 5 digital camera mounted on a Zeiss 
AxioImager M1 microscope, using a 10X objective lens and the MozaiX modul of the 
AxioVision 4.6 software (Carl Zeiss, Göttingen, Germany). Additional digital 
photomicrographs of single- and dual-labeled sections were prepared in bright-field 
mode. All digital images were processed with the Adobe Photoshop 7.1 software at 
300dpi resolution. Panels within the same figure were merged into a single image in 
which brightness and contrast were adjusted. 
 
Results 
General distribution of hybridization signals 
The autoradiographic detection of CB1, GAD65 and VGLUT2 mRNAs revealed 
highly patterned signal distributions in various septal-hypothalamic regions (Figs. 1 
and 2). In order to be considered specifically labeled with the radioactive probes, 
individual neurons had to exhibit at least 5 times higher autoradiographic signal (area 
covered by silver grains/selected total area) than the area fraction of silver grains in a 
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surrounding background region, as determined with the Image J software (public 
domain at http://rsb.info.nih.gov/ij/download/src/). No labeling was obtained 
following the use of sense transcripts.  
The incidences of neurons labeled for the three mRNAs varied from region to 
region. These variations were presented on arbitrary three point scales (“+”=low; 
”++”=moderate; “+++”=high; Columns 1-3 of Table 2) for each area and probe. High 
scores revealed the regions of extensive overlap between CB1 expressing neurons and 
distinct GABAergic and glutamatergic cell populations.  
In addition, labeled neurons also expressed variable single-cell levels of the signal. 
Another three point scale was used to rate the cellular intensity of labeling (“+”=low; 
”++”=moderate; “+++”=high) typical of labeled neurons in each area (Columns 4-6 
of Table 2). In case of CB1 mRNA, the low signal level (“+”) exceeded 5-10 times 
the level of non-specific background. Moderate signal (”++”) was 10-20 higher than 
background labeling, whereas high signal level (“+++”) was 20-50 times higher than 
non-specific background.  
Regional distribution of CB1 mRNA 
CB1-expressing neurons were found in high numbers (+++) in the lateral (LS) and 
medial (MS) septal nuclei, in the nuclei of the horizontal (HDB) and vertical (VDB) 
limbs of the diagonal band of Broca (DBB), in the medial preoptic area (MPA) and in 
the anteroventral periventricular (AVPe), median preoptic (MnPO), medial preoptic 
(MPO), supraoptic (SO), ventromedial (VMH), ventral premammillary (PMV) and 
lateral mammillary (LM) nuclei. The abundance of labeled neurons was moderate 
(++) in many other regions, such as the vascular organ of the lamina terminalis 
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(VOLT), the lateral preoptic area (LPO), the anterodorsal preoptic nucleus (ADP), the 
ventromedial preoptic nucleus (VMPO), the lateroanterior (LA), paraventricular (Pa), 
dorsal premammillary (PMD) and supramammillary (SuM) nuclei and the lateral 
hypothalamus (LH). Only few cells (+) contained CB1 mRNA in the arcuate (Arc; 
typically in the posterior part), suprachiasmatic (SCh), dorsomedial (DM) or medial 
mammillary (medial and lateral parts; MM, ML) nuclei. For results of the detailed 
topographic analysis, see column 1-3 in Table 2. For photographic illustrations, see 
Figs. 1 and 2. 
Cellular intensity of CB1 labeling 
The CB1 hybridization signal strength was low (+), moderate (++) or high (+++) in 
labeled septal and hypothalamic neurons and did not reach the heaviest (++++) CB1 
hybridization signal within the brain which was present in scattered interneurons of 
the neocortex (Fig. 3A), amygdala (Fig. 3B) and hippocampal formation (Fig. 3C) 
and in the majority of neurons of the lateral caudate putamen (CPu; Fig. 3D). 
Variations in the labeling intensity of septal-hypothalamic CB1-expressing neurons 
are illustrated in Fig. 3. Specifically, high single-cell CB1 mRNA levels (+++) were 
observed in the DBB (Figs. 1B, F and 3F) and the MS (Figs. 1B, F and 3E). Moderate 
levels (++) were typical of labeled neurons in several subdivisions of the preoptic 
region (Figs. 1F and J), including the medial preoptic area (MPA; Fig. 3G) and the 
medial preoptic nucleus (MPO; Fig. 3H). Moderate single-cell levels (++) were also 
observed in several hypothalamic nuclei, including the LA (Fig. 1N), Pa (Fig. 3L), 
VMH (Figs. 1R, 2B and 3J), LM (Figs. 2N, R and 3K), PMV (Figs. 2F and J), PMD 
(Fig. 2J), and LM (Figs. 2N and R). Neurons in the AVPe (Fig. 3I) and in numerous 
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hypothalamic regions including the SO (Fig. 3M) contained low single-cell levels (+) 
of the CB1 hybridization signal (although most neurons were labeled), which was 
sometimes only slightly above background labeling (+/-). If labeled, neurons of the 
Arc (especially caudally; Fig. 3N) and the Pe (Fig. 3O) also exhibited low signal 
levels only. 
Distribution of the GABAergic and glutamatergic marker mRNAs 
Typically, GAD65-expressing GABAergic and VGLUT2-expressing glutamatergic 
neurons exhibited distribution patterns complementary to one another (Figs. 1 and 2). 
GABA represented the dominant amino acid neurotransmitter phenotype in neurons 
of the MS (Figs. 1C, G), LS (Fig. 1C), HDB (Figs. 1C, G), VDB (Fig. 1C), in most 
subdivisions of the preoptic region (Figs. 1G and K), in the anterior hypothalamic 
area (Figs. 1O, S) and in the hypothalamic SCh (Fig. 1O), Arc (Figs. 2C, G) and DM 
(Fig. 2C) nuclei. Predominantly glutamatergic sites included the Pa (Figs. 1P, T), SO 
(Fig. 1P), VMH (Figs. 1T and 2D), LM (Figs. 2P, T), PMV (Figs. 2H, L), PMD (Fig. 
2L), medial mammillary (MM and ML; Figs. 2P, T), LM (Figs. 2P, T) and SuM 
(Figs. 2P, T) nuclei. Both GABAergic and glutamatergic neurons were present in 
high numbers in the AVPe (Figs. 1G, H). The regional abundance of GABAergic and 
glutamatergic neurons as well as the cellular intensity of labeling were scored on 
similar three point scales as for CB1 mRNA (For detailed results, see Table 2 and 
Figs. 1 and 2). 
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Overlaps between the distribution of CB1 mRNA with GABAergic and glutamatergic 
marker mRNAs 
The distribution of neurons with the highest cellular levels of CB1 mRNA (+++) in 
the MS, HDB and VDB overlapped with that of GAD65-expressing neurons (Figs. 
1A-D). Similarly, neurons with moderate single-cell CB1 mRNA levels (++) in the 
preoptic region, including the LPO, MPA and MPO, corresponded to dominantly 
GABAergic sites (Figs. 1E-L). Interestingly, all three mRNAs showed overlapping 
distributions in the AVPe (Figs. 1E-H). In contrast with the dominance of the 
CB1/GABA overlap at septal and preoptic sites, hypothalamic neurons exhibiting 
moderate (++) or low (+) cellular levels of CB1 mRNA rather tended to occur in 
areas populated by glutamatergic cells. Such CB1/glutamate regions included the 
VMH (Figs. 1R, T and 2B, D), LM (Figs. 2N, P and 2R, T), PMV (Figs. 2F, H and 
2J, L), PMD (Figs. 2J, L), SuM (Figs. 2N, P and 2R, T), SO (Figs. 1N, P) and Pa 
(Figs. 1N, P and 1R, T). Low levels of CB1 mRNA expression were detected in many 
other GABAergic and glutamatergic regions throughout the mouse hypothalamus 
(Figs. 1, 2). 
Dual-labeling experiments 
Dual-labeling experiments confirmed the colocalization of CB1 mRNA with the 
GABAergic (Fig. 4) and glutamatergic (Fig. 5) markers in regions where single-
labeling experiments revealed overlaps between CB1 with GAD65 and VGLUT2 
mRNAs, respectively.  
Examples for heavy (+++) CB1 signal in GABAergic cells were observed in the 
HDB (Fig. 4A). Moderate CB1 signal levels (++) were typical for GABAergic cells 
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of the MPA (Fig. 4C), MPO (Fig. 4D) and the different subdivisions of the anterior 
hypothalamic area (Figs. 4E, F). A small subset of GABAergic neurons in the SCh 
contained low levels of CB1 mRNA, whereas the majority of neurons were unlabeled 
(Fig. 4G). GABAergic neurons in many other regions including the AVPe (Fig. 4B), 
the DM (Fig. 4H) and the Arc (Fig. 4I) expressed CB1 mRNA at low levels (+) only.  
Examples for glutamatergic neurons with moderate levels of CB1 mRNA (++) were 
found in the HDB (Fig. 5A), LA (Fig. 5B), VMH (Fig. 5F), PMV (Fig. 5H) and LM 
(Fig. 5J). Low-to-moderate signal levels were also found in VGLUT2-expressing 
neurons of the AVPe (Fig. 5C), MPA (Fig. 5D), Pa (Fig. 5E), PMD (Fig. 5F) and 
SuM nuclei (Fig. 5K). Labeled glutamatergic neurons were also found in the Arc, 
most typically in its posterior part (Fig. 5G). 
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Discussion 
In the present report we provide a detailed map of septal-hypothalamic CB1 
mRNA-expressing neurons and demonstrate the differential colocalization of CB1 
with GAD65 and VGLUT2 mRNAs in distinct subsets of GABAergic and 
glutamatergic neurons, respectively.  
Differential expression of CB1 mRNA  
In this study, we present evidence for a wide and differential expression of CB1 
mRNA in septal-hypothalamic areas of the mouse. Overall, we found a much wider 
distribution of CB1 mRNA in the hypothalamus than reported earlier (Cota et al., 
2003; Marsicano and Lutz, 1999). To provide semiquantitative measures of regional 
differences in hybridization signal strength, we characterized distinct septal-
hypothalamic areas with both the regional abundance of CB1-expressing neurons and 
the typical single-cell level of CB1 hybridization signal, on three point scales, each. 
The CB1 signal strength of individual septal-hypothalamic neurons was always lower 
than the CB1 labeling intensity of a subset of GABAergic neurons in the basolateral 
amygdala (Herkenham et al., 1990; Katona et al., 2001; Katona et al., 1999; 
Marsicano and Lutz, 1999; Matsuda et al., 1993; McDonald and Mascagni, 2001; 
Tsou et al., 1998), hippocampus (Herkenham et al., 1990; Katona et al., 2001; Katona 
et al., 1999; Marsicano and Lutz, 1999; Matsuda et al., 1993; McDonald and 
Mascagni, 2001; Tsou et al., 1998) or cerebral cortex (Bodor et al., 2005). In 
comparison with the very heavy (++++) CB1 signal in cholecystokinin containing 
basket cells of these sites (Cota et al., 2003; Marsicano and Lutz, 1999), the labeling 
intensity of septal-hypothalamic neurons ranged from low (–) to high (+++).   
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GABAergic neurons expressing CB1 mRNA 
 The highest cellular levels of CB1 mRNA expression (+++) in our regions of 
interest were observed in GABAergic neurons in the MS, HDB and VDB; these 
GABAergic cells have been implicated in spatial learning and memory (Pang et al.). 
Various cognitive processes of the hippocampus depend on the theta rhythm which is 
generated and propagated to the hippocampus by GABAergic neurons located in the 
MS-DBB complex (Borhegyi et al., 2004; Varga et al., 2008) which selectively 
innervate GABAergic interneurons in the hippocampus (Freund and Antal, 1988). 
There is evidence that CB1 receptor activation reduces hippocampal theta 
oscillations, with concomitant memory impairment in hippocampus-dependent tasks. 
We found additional evidence for the presence of somewhat lower levels of CB1 
mRNA in glutamatergic neurons in the MS-DBB region. Further, cholinergic neurons 
also appear to contain CB1 at this site (Nyiri et al., 2005) and the CB1 agonist WIN 
55212-2 directly inhibits their acetylcholine release into the hippocampus (Gifford 
and Ashby, 1996). 
 In our studies to analyze the coexpression of CB1 and GAD65 mRNAs, we found 
moderate CB1 mRNA levels in GABAergic neurons of several preoptic regions, 
including the MPO, LPA and the MnPO and somewhat lower levels in the AVPe. 
From a neuroendocrine aspect, a particularly interesting observation was the presence 
of CB1 expression in the AVPe which represents an important source for neuronal 
inputs to gonadotropin-releasing hormone (GnRH) neurons (Herbison, 2008). The 
presence of CB1 in this putative GABAergic input system to GnRH neurons may 
explain our recent electrophysiological and morphological data that retrograde 
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endocannabinoid signaling reduces GABAergic afferent drive onto GnRH neurons 
via the activation of presynaptic CB1 receptors (Farkas et al., 2010). In that study we 
have provided evidence that GnRH neurons produce 2-arachidonoylglycerol (2-AG). 
Its presynaptic action via CB1 decreases GABA release, which, in turn, reduces 
postsynaptic GABAA-R signaling and inhibits the firing activity of GnRH neurons 
(Farkas et al., 2010).  
 In contrast with the high and moderate levels of CB1 mRNA expression in septal 
and preoptic GABAergic neurons, GABAergic cells in the hypothalamus tended to 
express low levels of CB1 mRNA, only. Where present, moderate levels of CB1 
signal were more typical for hypothalamic glutamatergic neurons. The colocalization 
of hypothalamic CB1 and GAD65 mRNAs in our study somewhat conflicts with the 
lack of evidence for CB1 mRNA in hypothalamic GABAergic cells (Cota et al., 
2003; Marsicano and Lutz, 1999). It is likely that these previous studies failed to 
reveal the relatively low levels of CB1 expression in GABAergic cells, given that 
CB1 mRNA expression tends to be heavier in glutamatergic vs. GABAergic systems 
of the hypothalamus,  
Glutamatergic neurons with the highest cellular levels of CB1 mRNA expression 
 Glutamatergic neurons also occurred in the MS, HDB and DBB and expressed CB1 
mRNA, albeit at slightly lower levels than did GABAergic neurons.  
 Among the various compartments of the preoptic region which contained 
glutamatergic, in addition to GABAergic neurons, the AVPe showed an interesting 
overlap of CB1, GAD65 and VGLUT2 mRNAs; Usually low levels of CB1 
expression were detectable here in glutamatergic, in addition to GABAergic neurons. 
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From a neuroendocrine aspect, it is interesting to note that the AVPe contains 
GABAergic/glutamatergic dual-phenotype neurons in female rats, which innervate 
GnRH cells (Ottem et al., 2004) and mediate positive sex steroid feedback effects 
(Herbison, 2008).  
Regarding the hypothalamus, the highest regional abundance of CB1 mRNA 
expression and the highest single-cell levels of CB1 mRNA tended to occur in 
glutamatergic regions. As we have shown in a previous (Hrabovszky et al., 2005) and 
the present studies, the bulk of the VMH consists of VGLUT2-expressing 
glutamatergic neurons in rodents. Presence of CB1 mRNA in these cells is in 
accordance with previous observations by others (Marsicano and Lutz, 1999) and 
suggests that glutamate release from hypothalamic and extrahypothalamic synapses 
of these neurons is modulated by endocannabinoids synthesized in postsynaptic target 
cells. The VMH establishes terminal fields in other parts of the medial hypothalamus, 
sends ascending projections to the zona incerta, the midline thalamus, the bed nuclei 
of the stria terminalis, the amygdala, the nucleus accumbens and the prefrontal cortex. 
Its descending projections reach the periaqueductal gray, the superior colliculus, 
peripeduncular area, locus coeruleus, Barrington's nucleus, parabrachial nucleus, 
nucleus of the solitary tract, and the mesencephalic, pontine, gigantocellular, 
paragigantocellular and parvicellular reticular nuclei (Canteras et al., 1994; Krieger et 
al., 1979; Saper et al., 1976). The VMH possesses massive intrinsic connections 
(Canteras et al., 1994; Millhouse, 1973; Nishizuka and Pfaff, 1989). Therefore, a 
major site of action on CB1 that is synthesized in the nucleus may be within the VMH 
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itself. It is likely that the massive CB1-immunoreactive innervation of the VMH we 
reported earlier (Wittmann et al., 2007) arises partly from local neurons.  
From a functional aspect, the VMH is involved heavily in the integration of 
forebrain neural influences with ascending information from the brainstem, and 
distributing the resulting output to regions involved in the control of visceral and 
behavioral mechanisms (Swanson and Mogenson, 1981). Functions associated with 
the VMH include the control of pituitary hormone release (Blache et al., 1991; 
Chateau et al., 1984; Kato et al., 1983; Okada et al., 1991; Pan and Gala, 1985). 
Furthermore, VMH lesions interfere with the diurnal rhythms of plasma 
corticosterone levels and food intake (Balagura and Devenport, 1970; Bellinger et al., 
1976; Bernardis, 1973). There is also general agreement that the VMH plays 
important roles in the regulation of feeding (Brooks et al., 1946; Minano and Myers, 
1991; Perkins et al., 1981; Shimizu et al., 1987), defensive (Fuchs et al., 1985a; b), 
and feminine copulatory behaviors and the modulation of autonomic responses 
associated with these behaviors.  
The LH also contained moderate numbers of CB1-expressing glutamatergic 
neurons. This anatomical site has been strongly implicated in the regulation of energy 
balance (Richard et al., 2009). A subset of CB1-expressing neurons in the LH may 
correspond to melanin concentrating hormone producing neurons that were 
previously shown to express CB1 (Cota et al., 2003). 
The LA contained a glutamate/CB1 cell population that was distinct from the 
glutamate/CB1 neurons of the LH. In the rat, this anatomical region forms part of the 
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hypothalamic attack area and contains VGLUT2-expressing neurons that co-
synthesize thyrotropin-releasing hormone (Hrabovszky et al., 2005).   
The medial and lateral mammillary nuclei play a crucial role in episodic memory. 
Some degree of parallelism exists both in the inputs and the outputs of these nuclei 
(Vann and Aggleton, 2004). Significant afferent sources include the hippocampal 
formation and the tegmental nuclei, whereas the excitatory efferents target the 
anterior thalamic nuclei via the mammillothalamic tract and the tegmental nuclei via 
the mammillotegmental tract (Hayakawa and Zyo, 1989). Both the medial and the 
lateral mammillary nuclei comprised VGLUT2-expressing glutamatergic neurons in 
our study, but only cells in the LM showed detectable levels of CB1 mRNA. The 
functional significance of this differential CB1 expression requires clarification. 
Other nuclei with high levels of CB1 and VGLUT2 mRNAs included the PMV. 
This site has been heavily implicated in reproductive regulation. Its neurons 
expressing cocaine- and amphetamine-regulated transcript project to the preoptic area 
(Rondini et al., 2010). Cells of the PMV express a dense concentration of leptin 
receptors which appear to play a role in linking changing levels of leptin and 
coordinated control of reproduction. Lesions of the PMV disrupt estrous cyclicity in 
rats and preclude the stimulation of luteinizing hormone secretion by leptin during 
fasting (Donato et al., 2009). Other regions where CB1 and VGLUT2 mRNAs were 
frequently coexpressed included the LM, PMD, SuM, SO and Pa nuclei. 
Cells expressing low levels or no CB1 
Neurons expressing low levels or no CB1 mRNA should also be noted. 
Accordingly, the large GABAergic cell mass in the lateral septum, the majority of 
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GABAergic neurons in the SCh and the Arc exhibited either no or only low levels of 
CB1 hybridization signal. Glutamatergic neurons in the medial mammillary nucleus 
were similarly devoid of CB1 mRNA. While the activity of such neurons may also 
regulate endocannabinoid production in their postsynaptic targets, it is likely that their 
own neurotransmitter release is independent of retrograde endocannabinoid signaling 
by the postsynaptic neurons.      
CB1 in neuroendocrine cells 
Parvicellular and magnocellular neuroendocrine cells project outside the blood-
brain barrier and release their neurohormone contents in the blood stream to regulate 
endocrine functions. Previous studies from our laboratory found that most of the 
classical neuroendocrine cells in the rat, with the exception of dopaminergic and 
growth hormone-releasing hormone neurons in the Arc nucleus, express VGLUT2 
mRNA (Hrabovszky and Liposits, 2008). In the present studies we identified large 
numbers of CB1/VGLUT2 dual-labeled neurons in the SO, although individually, 
these cells contained low CB1 mRNA levels only. These neurons are exclusively 
magnocellular neurosecretory cells which secrete oxytocin and vasopressin into the 
peripheral circulation. Similarly, the Pa also contained many parvicellular 
CB1/VGLUT2 neurons some of which could also be neuroendocrine cells. 
Accordingly, a previous dual-label in situ hybridization study by Cota and co-workers 
provided evidence that a subset of CB1 neurons in this nucleus expresses 
corticotropin-releasing hormone mRNA (Cota et al., 2003). Furthermore, our 
previous immunocytochemical study (Wittmann et al., 2007) identified CB1-
immunoreative axon terminals in the external layer of the median eminence where 
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parvicellular neurosecretory systems project. Future dual-label immunofluorescent 
experiments will need to clear the neuropeptide phenotypes of these CB1 containing 
neuroendocrine terminals. From a conceptual viewpoint, it will be important to 
identify the glial, endothelial, or neuronal sources of endogenous cannabinoids at 
these neuroendocrine secretion sites. Tanycytes, which exhibit immunoreactivity for 
the endocannabinoid biosynthetic enzyme diacylglycerol lipase, represent one likely 
source for 2-AG that affects CB1-containing parvicellular neurosecretory axon 
terminals (Suarez et al., 2010). Functional studies will need to determine the 
physiological significance of CB1 in parvicellular and magnocellular neurosecretory 
systems. 
Technical considerations 
Because hypothalamic neurons express relatively low levels of CB1 mRNA 
(Marsicano and Lutz, 1999), in the present study we chose to use an improved 
radioisotopic hybridization procedure (Hrabovszky and Petersen, 2002). With this 
method, a low autoradiographic background can be achieved via the use of high 
dithiothreitol concentrations (1000mM) in the hybridization solution. This 
modification allows the use of enhanced radioisotopic probe (80,000 cpm/ml) and 
dextran sulfate (20%) concentrations in the hybridization solution, increasing thus the 
specific hybridization signal. This method has also been adapted successfully to dual-
label in situ hybridization (Hrabovszky et al., 2004; Hrabovszky et al., 2006). In the 
present study we have noticed that while increased concentration of dextran sulfate 
can, indeed, significantly enhance the isotopic signal for CB1 mRNA, it actually 
weakens the signal using the digoxigenin-labeled probes for GAD65 and VGLUT2. 
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Therefore, in order to achieve the sufficient visualization of GABAergic and 
glutamatergic neurons, we have modified the dual-labeling procedure by using high 
isotopic probe, but not dextran sulfate, concentrations. This necessary compromise 
could somewhat reduce the sensitivity of CB1 mRNA detection.  
As we stated and discussed in a previous technical report (Hrabovszky and 
Petersen, 2002), the finding of increased hybridization signal following the use of 
enhanced probe and/or dextran sulfate concentrations in the hybridization solution, or 
an enhanced hybridization time, collectively suggest that the “saturation” of mRNA 
targets can not be achieved using routine in situ hybridization procedures with 
isotopic cRNA probes. This also implies that the in situ hybridization reaction does 
not follow pseudo-first order kinetics, as postulated for nucleic acid hybridization to 
immobilized targets (Hrabovszky and Petersen, 2002). Use of an improved 
hybridization method could be important in the present study to visualize low levels 
of CB1 mRNA in neurons previously reported not to have significant levels of CB1 
mRNA, including GABAergic hypothalamic neurons (Marsicano and Lutz, 1999). It 
is still important to note that practical limits exist in enhancing the hybridization 
signal via using improved methods. Increasing probe and/or dextran sulfate 
concentration beyond some point will also result in increased background. Also, the 
visualization of isotopic probes at the single-cell level can be quite insensitive and in 
case of rare mRNA targets, grain clusters might not appear in the emulsion even after 
long exposures. Furthermore, while the in situ formed probe RNA/mRNA hybrids are 
considered stabile based on theoretical considerations, in our experience a quite 
robust decrease of the specific hybridization signal can also result from too harsh 
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posthybridization RNase A- and stringent treatments. Therefore, negative results 
including the lack of CB1 hybridization signal in significant subsets of hypothalamic 
neurons should be interpreted with caution and not as a functional proof for the 
insensitivity of these cells to endocannabinoids.  
In summary, in this report we present a detailed neuroanatomical map of 
GABAergic and glutamatergic septal-hypothalamic neurons that express CB1 
mRNA. Neurotransmitter release from these cells is controlled by retrograde 
endocannabinoid signaling from target neurons. This neuroanatomical information 
may help to understand the role of the endocannabinoid system in the regulation of 
endocrine and metabolic functions. 
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Figure 1. Comparative distribution of CB1, GAD65 and VGLUT2 hybridization 
signals in septal-rostral hypothalamic areas of the mouse.  
The radioisotopic in situ hybridization detection of CB1 (B, F, J, N, R), GAD65 (C, 
G, K, O, S) and VGLUT2 (D, H, L, P, T) mRNAs in autoradiographic emulsion 
reveals CB1 mRNA expression in areas populated by GABAergic (GAD65 mRNA-
expressing) as well as glutamatergic (VGLUT2 mRNA-expressing) neurons. The 
regional abundance of CB1 mRNA is high (+++) in the HDB (B, F), VDB (B) and 
the MS (B, F); these regions are dominated by GABAergic neurons (C, G). Similarly, 
CB1 labeling in most subdivisions of the preoptic region (F, J) also tends to overlap 
with the distribution of GABAergic neurons (G, K). Note that the AVPe contains 
overlapping CB1, GAD65 and VGLUT2 signals (F-H). The highest regional 
expression of CB1 mRNA in the rostral hypothalamus can be observed in glutamate-
dominated nuclei, including the LA, SO, Pa, and VMH (N-T). GABAergic 
hypothalamic sites, including the AHA and AHP, express lower levels of the CB1 
hybridization signal (N-T). Note the well-patterned and complementary distributions 
of GABAergic and glutamatergic neurons. For a list of abbreviations and the results 
of the detailed regional analysis, see Tables 1 and 2, respectively. Scale bar=200µm. 
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Figure 2. Comparative distribution of CB1, GAD65 and VGLUT2 hybridization 
signals in the caudal hypothalamus of the mouse. 
Autoradiographic images of neighboring sections from the caudal hypothalamus 
illustrate the distributions of CB1 (B, F, J, N, R), GAD65 (C, G, K, O, S) and 
VGLUT2 (D, H, L, P, T) mRNAs. Similarly to the rostral hypothalamus, CB1 
expression tends to be more abundant in glutamatergic vs. GABAergic regions, 
including the VMH (B), PMV (F, J), PMD (J), SuM (N, R) and LM (N, R) nuclei. 
CB1 mRNA expression can be observed in the DM (B) where both GABAergic (C) 
and glutamatergic (D) neurons occur. Several sites with GABAergic dominance, 
including the Arc (B, F, J), exhibit lower levels of CB1 expression, with somewhat 
more labeled neurons caudally (F, J). For a list of abbreviations and the results of the 
detailed regional analysis, see Tables 1 and 2, respectively. Scale bar=200µm. 
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Fig. 3. Representative autoradiographic images of septal-hypothalamic neurons 
with different single-cell levels of CB1 mRNA. In situ hybridization experiments 
reveal the most intense CB1 labeling (++++) in subsets of interneurons in the 
neocortex (Ctx; A), amygdala (B) and hippocampal formation (C). CB1 is also 
expressed very heavily (++++) in the majority of neurons in the lateral caudate 
putamen (CPu; D). Such heavy expression is never observed in septal-hypothalamic 
neurons; if labeled, these neurons exhibit CB1 signal levels that range from low (+) to 
high (+++). High signal (+++) is present in a subset of neurons in the diagonal band 
of Broca (E) and the medial septum (F). Moderate signal levels (++) are typical for 
neurons in several subdivisions of the preoptic region, including the medial preoptic 
area (MPA; G) and the medial preoptic nucleus (MPO; H). These sites are dominated 
by GABAergic cells (see Fig. 1). Most neurons in the anteroventral periventricular 
nucleus (AVPe; I) express CB1 mRNA at low levels. Moderate signal levels 
characterize neurons in the hypothalamic ventromedial (VMH; J), lateral mammillary 
(LM, K), and paraventricular nuclei (Pa; L). These hypothalamic sites are dominated 
by glutamatergic cells (see Figs. 1 and 2). Low levels (+) of CB1 mRNA are 
expressed at many other sites. Accordingly, low levels are typical for neurons of the 
supraoptic (SO; M), posterior arcuate (Arc post; N) and periventricular (Pe; O) 
nuclei, among other sites. Arrows in all panels point to representative neurons used 
for scaling for the cellular intensity of labeling. In addition, note that the regional 
abundance of labeled neurons varies significantly. For scoring, see Table 2. 
Abbreviations: BMA, basomedial amygdaloid nucleus, anterior part; Ctx, 
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(retrosplenial granular) cortex; DG, dentate gyrus; HDB, nucleus of the horizontal 
limb of the diagonal band. Scale bar=50 µm. 
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Fig. 4. Representative dual-label in situ hybridization images of GABAergic 
neurons expressing CB1 mRNA from different coronal planes of the mouse 
septal-hypothalamic region. GAD65-expressing GABAergic neurons (purple 
alkaline phosphatase substrate) exhibit heavy (+++) hybridization signal (clusters of 
autoradiographic grains) in the HDB (A). Panels B-F illustrate the low to moderate 
intensity of CB1 labeling (+, ++) in large populations of GABAergic neurons in the 
AVPe (B), MPA (C), MPO (D), the AHC (E) and AHP (F). Note the small subset of 
GABAergic neurons in the suprachiasmatic nucleus (SCh; G) that express low levels 
of CB1 mRNA, whereas most cells are devoid of any CB1 labeling. GABAergic cells 
of the DM (H) and Arc (I) nuclei contain low levels of signal, if any. Arrows in all 




Fig. 5. Representative dual-label in situ hybridization images of glutamatergic 
neurons expressing CB1 mRNA at different coronal planes of the mouse septal-
hypothalamic region. Glutamatergic neurons (purple perikarya) express moderate 
levels (++) of CB1 mRNA (clusters of silver grains) in the HDB (A). Compare to the 
heavier CB1 signal over GABAegic neurons in 3A. Moderate levels of CB1 signal 
can be observed over hypothalamic glutamatergic neurons of the LA (B), VMH (F), 
PMV (H) and LM (J) nuclei. Low to moderate levels of CB1 mRNA expression can 
be observed in glutamatergic cells of the AVPe (C) nucleus, the MPA (D), the Pa (E), 
posterior Arc (Arc post; G), PMD (I) and SuM (K) nuclei. Arrows point to dual-
labeled neurons. See Table 1, for a list of abbreviations. Scale bar=50 µm. 
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Table 1. List of abbreviations used in text and figures. 
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Table 2. Regional and single-cell abundances of radioisotopic in situ 
hybridization signals for CB1, GAD65 and VGLUT2 mRNAs in septal-preoptic-
hypothalamic regions of the mouse. 





